Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II

BACKGROUND: Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their capacity to modulate the immune system and suppress cytokine storms caused by SARS-CoV-2. This prospective randomized double-blind placebo-controlled clinical trial aimed to assess the safety and efficacy of sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathi-Kazerooni, Mina, Fattah-Ghazi, Samrand, Darzi, Maryam, Makarem, Jalil, Nasiri, Reza, Salahshour, Faeze, Dehghan-Manshadi, Seyed Ali, Kazemnejad, Somaieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899458/
https://www.ncbi.nlm.nih.gov/pubmed/35255966
http://dx.doi.org/10.1186/s13287-022-02771-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899458/
https://www.ncbi.nlm.nih.gov/pubmed/35255966
http://dx.doi.org/10.1186/s13287-022-02771-w

Ejemplares similares